...
首页> 外文期刊>PLOS Neglected Tropical Diseases >First International External Quality Assessment of Molecular Detection of Crimean-Congo Hemorrhagic Fever Virus
【24h】

First International External Quality Assessment of Molecular Detection of Crimean-Congo Hemorrhagic Fever Virus

机译:克里米亚-刚果出血热病毒分子检测的首次国际外部质量评估

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Crimean-Congo hemorrhagic fever (CCHF) is a zoonosis caused by a Nairovirus of the family Bunyaviridae. Infection is transmitted to humans mostly by Hyalomma ticks and also by direct contact with the blood or tissues of infected humans or viremic livestock. Clinical features usually include a rapid progression characterized by hemorrhage, myalgia and fever, with a lethality rate up to 30%. CCHF is one of the most widely distributed viral hemorrhagic fevers and has been reported in Africa, the Middle East and Asia, as well as parts of Europe. There is no approved vaccine or specific treatment against CCHF virus (CCHFV) infections. In this context, an accurate diagnosis as well as a reliable surveillance of CCHFV infections is essential. Diagnostic techniques include virus culture, serology and molecular methods, which are now increasingly used. The European Network for the Diagnostics of “Imported” Viral Diseases organized the first international external quality assessment of CCHVF molecular diagnostics in 2011 to assess the efficiency and accurateness of CCHFV molecular methods applied by expert laboratories. A proficiency test panel of 15 samples was distributed to the participants including 10 different CCHFV preparations generated from infected cell cultures, a preparation of plasmid cloned with the nucleoprotein of CCHFV, two CCHFV RNA preparations and two negative controls. Forty-four laboratories worldwide participated in the EQA study and 53 data sets were received. Twenty data sets (38%) met all criteria with optimal performance, 10 (19%) with acceptable performance, while 23 (43%) reported results showing a need for improvement. Differences in performance depended on the method used, the type of strain tested, the concentration of the sample tested and the laboratory performing the test. These results indicate that there is still a need for improving testing conditions and standardizing protocols for the molecular detection of Crimean-Congo hemorrhagic fever virus.
机译:克里米亚-刚果出血热(CCHF)是由Bunyaviridae家族的奈洛病毒引起的人畜共患病。感染主要通过透明膜tick虫传播,也通过与被感染的人类血液或病毒性牲畜的血液或组织直接接触而传播给人类。临床特征通常包括以出血,肌痛和发烧为特征的快速进展,致死率高达30%。 CCHF是分布最广泛的病毒性出血热之一,在非洲,中东和亚洲以及欧洲部分地区已有报道。没有针对CCHF病毒(CCHFV)感染的批准疫苗或特殊治疗方法。在这种情况下,准确诊断和可靠监测CCHFV感染至关重要。诊断技术包括病毒培养,血清学和分子方法,这些技术现在越来越多地被使用。 “进口的”病毒性疾病欧洲诊断网络在2011年组织了CCHVF分子诊断的首次国际外部质量评估,以评估专家实验室采用的CCHFV分子方法的效率和准确性。将15个样品的能力测试小组分配给参与者,包括从感染的细胞培养物中产生的10种不同的CCHFV制剂,用CCHFV核蛋白克隆的质粒制剂,两种CCHFV RNA制剂和两种阴性对照。全球有44个实验室参加了EQA研究,并接收了53个数据集。二十组数据(38%)符合所有标准,具有最佳性能,十组(19%)可接受的性能,而23组(43%)报告的结果表明需要改进。性能差异取决于所使用的方法,测试的菌株类型,测试样品的浓度以及进行测试的实验室。这些结果表明,仍然需要改善测试条件和标准化协议,以对克里米亚-刚果出血热病毒进行分子检测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号